Sodium Hydroxide → N2,N7-bis(4-tert-butylcyclohexyl)-N2,N7-bis(3-(dimethylamino)propyl)-9,10-dioxo-9,10-dihydroanthracene-2,7-disulfonamide

HRID 61979

반응식

HRID 61979 반응식
[C:1]([CH:5]1[CH2:10][CH2:9][CH:8]([NH:11][S:12]([C:15]2[CH:28]=[CH:27][C:26]3[C:25](=[O:29])[C:24]4[C:19](=[CH:20][C:21]([S:30]([NH:33][CH:34]5[CH2:39][CH2:38][CH:37]([C:40]([CH3:43])([CH3:42])[CH3:41])[CH2:36][CH2:35]5)(=[O:32])=[O:31])=[CH:22][CH:23]=4)[C:18](=[O:44])[C:17]=3[CH:16]=2)(=[O:14])=[O:13])[CH2:7][CH2:6]1)([CH3:4])([CH3:3])[CH3:2].[H-].[Na+].Cl.Cl[CH2:49][CH2:50][CH2:51][N:52]([CH3:54])[CH3:53].[OH-].[Na+]>CN(C=O)C>[C:1]([CH:5]1[CH2:10][CH2:9][CH:8]([N:11]([CH2:49][CH2:50][CH2:51][N:52]([CH3:54])[CH3:53])[S:12]([C:15]2[CH:28]=[CH:27][C:26]3[C:25](=[O:29])[C:24]4[C:19](=[CH:20][C:21]([S:30]([N:33]([CH:34]5[CH2:35][CH2:36][CH:37]([C:40]([CH3:43])([CH3:42])[CH3:41])[CH2:38][CH2:39]5)[CH2:49][CH2:50][CH2:51][N:52]([CH3:54])[CH3:53])(=[O:31])=[O:32])=[CH:22][CH:23]=4)[C:18](=[O:44])[C:17]=3[CH:16]=2)(=[O:13])=[O:14])[CH2:7][CH2:6]1)([CH3:4])([CH3:3])[CH3:2]

참가 물질

6

반응물 4

HCID 14798Sodium HydroxideHCID 24758Sodium hydrideHCID 943083-(Dimethylamino)propyl chloride hydrochlorideHCID 46851178N2,N7-bis(4-tert-butylcyclohexyl)-9,10-dioxo-9,10-dihydroanthracene-2,7-disulfonamide

생성물 1

HCID 46852320N2,N7-bis(4-tert-butylcyclohexyl)-N2,N7-bis(3-(dimethylamino)propyl)-9,10-dioxo-9,10-dihydroanthracene-2,7-disulfonamide수율 19.6%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

반응 조건

온도
40 °C

실험 절차

To an ice cold solution of the sulfonamide (1-36, 6.82 g, 10.61 mmol) in anhydrous DMF (100 ml) under argon was added NaH (95.0%, 697 mg, 27.58 mmol). The solution was stirred for 5 min, and then 3-chloro-N,N-dimethylpropan-1-amine hydrochloride (2.18 g, 13.8 mmol) was added. After 10 min, the reaction mixture was transferred to a pre heated oil bath at 40° C. and stirred for 3 days. LCMS showed the presence of monoalkylated and bisalkylated products (ratio, 65:25) together with unreacted starting material. After cooling, 1N NaOH was added to the reaction mixture and extracted with ethyl acetate. The organic phase was dried over anhydrous magnesium sulfate and the filtrate was evaporated under reduced pressure. The crude mixture was purified by silica gel column chromatography. The unreacted starting material was recovered when the column was eluted with 40° A) EtOAc in hexane. Pure monoalkylated product (13-1, LCMS, MS 728.0 (MH+)) was obtained when eluted using EtOAc alone and the bisalkylated product (1-70, LCMS, MS 813.2 (MH+)) was isolated with 5% triethylamine in EtOAc as the eluent. The fractions collected were evaporated under reduced pressure to dryness to get 13-1 (3.02 g, 53%) and 1-70 (1.10 g, 17%).

후처리

  1. waitAfter 10 min
  2. stirringstirred for 3 days
  3. temperatureAfter cooling
  4. extractionextracted with ethyl acetate
  5. dry with materialThe organic phase was dried over anhydrous magnesium sulfate
  6. customthe filtrate was evaporated under reduced pressure
  7. customThe crude mixture was purified by silica gel column chromatography
  8. customwas recovered when the column
  9. washwas eluted with 40° A) EtOAc in hexane
  10. customPure monoalkylated product (13-1, LCMS, MS 728.0 (MH+)) was obtained when
  11. washeluted
  12. customthe bisalkylated product (1-70, LCMS, MS 813.2 (MH+)) was isolated with 5% triethylamine in EtOAc as the eluent
  13. customThe fractions collected
  14. customwere evaporated under reduced pressure to dryness

출처 및 근거

ORD 기록
ord-17935486f6c84e459d4ca9b7814ed52d
출처 데이터셋
uspto-grants-2016_09
특허 번호
US09446021B2

연결된 노트

불러오는 중…